The relationship between the level of Lр(а) and the prevalence of atherosclerosis among young patients

The relationship between the level of Lр(а) and the prevalence of atherosclerosis among young patients

Background. Hyperlipoproteinemia (a) is an independent and cause risk factor for atherosclerotic cardiovascular diseases (ASCVD). The correlation between lipoprotein (a) Lp(a) and inflammation in the vessel wall was actively studied during the past few years. C-reactive protein (CRP) plays an impor...

Full description

Bibliographic Details
Main Authors:	Elena A. Klesareva, Olga I. Afanasieva, Ekaterina E. Sherstyuk, Narek A. Tmoyan, Oksana A. Razova, Aleksandra V. Tyurina, Marina I. Afanasieva, Marat V. Ezhov, Sergei N. Pokrovsky
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2022-05-01
Series:	Терапевтический архив
Subjects:	atherosclerosis lipoprotein a c-reactive protein multifocal atherosclerosis systemic inflammation neutrophil to lymphocyte ratio
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/48346/pdf

Similar Items

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries
by: Marat V. Ezhov, et al.
Published: (2021-02-01)

The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease
by: N A Tmoyan, et al.
Published: (2018-09-01)

The Concentration of PCSK9-Lp(a) Complexes and the Level of Blood Monocytes in Males with Coronary Atherosclerosis
by: Anastasiia Yu. Filatova, et al.
Published: (2023-06-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Lipoprotein(a) concentration and the blood content of INFγ-producing T-helpers 17 (Th17/1) in males with premature coronary artery disease
by: A. Yu. Filatova, et al.
Published: (2022-07-01)

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level
by: Olga Afanasieva, et al.
Published: (2020-10-01)

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease
by: Narek A. Tmoyan, et al.
Published: (2021-01-01)

Hyperlipoproteinemia(a) as a dangerous genetically determined violation of lipid metabolism and a risk factor for atherothrombosis and cardiovascular diseases
by: O. I. Afanasieva, et al.
Published: (2019-06-01)

Association of the increased circulating CD62LloCXCR4hi neutrophil count with carotid atherosclerosis
by: I. I. Dolgushin, et al.
Published: (2021-05-01)

Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis
by: A. Yu. Filatova, et al.
Published: (2019-06-01)

Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels
by: Marat Ezhov, et al.
Published: (2019-03-01)

Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease
by: Olga I. Afanasieva, et al.
Published: (2023-10-01)

Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis
by: O I Afanasievа, et al.
Published: (2016-09-01)

The role of atherosclerosis risk factors in development of coronary artery disease in young men
by: M V Ezhov, et al.
Published: (2009-05-01)

Features of atherosclerosis in carotid and coronary arteries
by: E. V. Konstantinova, et al.
Published: (2021-10-01)

RAISED LEVEL OF LIPOPROTEIDE(A) AS A PREDICTOR OF CARDIOVASCULAR COMPLICATION POST REVASCULARIZATION OF THE LOWER ExTREMETIES ARTERIES
by: N. A. Tmojan, et al.
Published: (2018-09-01)

CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE
by: O. I. Afanasieva, et al.
Published: (2016-01-01)

Hyperlipoproteinemia(a) and Severe Coronary Artery Lesion Types
by: Larisa N. Ilina, et al.
Published: (2022-11-01)

Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease
by: Olga I. Afanasieva, et al.
Published: (2022-02-01)

RAISED IgM AUTOANTIBODY TITER TO LIPOPROTEIDE(A) AS ANTIATHEROGENIC FACTOR IN SEVERE HYPERCHOLESTEROLEMIA PATIENTS
by: E. A. Klesareva, et al.
Published: (2018-09-01)

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
by: N. E. Gavrilova, et al.
Published: (2016-10-01)

Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus
by: V V Genkel, et al.
Published: (2019-10-01)

The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis
by: Olga I. Afanasieva, et al.
Published: (2021-06-01)

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis
by: Uliana V. Chubykina, et al.
Published: (2022-01-01)

Association of various lipid parameters with premature coronary artery disease in men
by: A. V. Tyurina, et al.
Published: (2022-07-01)

High density lipoproteins and atherosclerosis II /
by: International Symposium on High Density Lipoproteins and Atherosclerosis (2nd : 1988 : Maidstone, England), et al.
Published: (1989)

The Importance of Lipoprotein Lipase Regulation in Atherosclerosis
by: Anni Kumari, et al.
Published: (2021-07-01)

Recent progress in the management of atherosclerosis and hyperlipidemia
by: M. V. Ezhov
Published: (2017-12-01)

Interactions between immunosuppressor neutrophiles, innate and adaptive immunity indexes in the patients with subclinical atherosclerosis
by: I. I. Dolgushi, et al.
Published: (2022-04-01)

Clinical and prognostic importance of assessment of interleukin-12 blood concentration in patients with multifocal atherosclerosis after carotid endarterectomy
by: A. V. Frolov, et al.
Published: (2014-06-01)

Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events?
by: O. L. Barbarash, et al.
Published: (2020-09-01)

Lp(a) and inflammation: a new insight into atherosclerosis
by: Hangyu Pan, et al.
Published: (2023-10-01)

Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
by: O L Barbarash, et al.
Published: (2019-12-01)

Role of blood cholesterol transport system disturbances in atherosclerosis development in rheumatoid arthritis
by: T. V. Popkova, et al.
Published: (2007-10-01)

Risk factors for and prognostic value of multifocal atherosclerosis in patients with diabetes mellitus
by: S A Gracheva, et al.
Published: (2014-10-01)

THE ROLE OF MULTIFOCAL ATHEROSCLEROSIS IN DEVELOPMENT OF UNFAVORABLE CARDIOVASCULAR OUTCOMES IN PATIENTS AFTER CORONARY BYPASS GRAFTING
by: L. S. Barbarash, et al.
Published: (2016-02-01)

Biochemical markers of atherosclerosis
by: Đerić Mirjana, et al.
Published: (2008-01-01)

RELATIONSHIP OF MULTIFOCAL ATHEROSCLEROSIS AND RENAL DYSFUNCTION WITH IN-HOSPITAL COMPLICATIONS AFTER CORONARY BYPASS OPERATION IN ISCHEMIC HEART DISEASE
by: K. S. Shafranskaya, et al.
Published: (2015-03-01)

Atherosclerosis vaccine: the present and the future
by: M. I. Dushkin
Published: (2011-06-01)